Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Glycolipid antigens for treating hepatic colorectal cancer metastases and their effect on the therapeutic efficacy of live attenuated Listeria monocytogenes.

Olino K, Edil BH, Meckel KF, Pan X, Thuluvath A, Pardoll DM, Schulick RD, Yoshimura K, Weber WP.

Arch Surg. 2012 May;147(5):480-2. doi: 10.1001/archsurg.2011.2206.

2.

Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells.

Yoshimura K, Laird LS, Chia CY, Meckel KF, Slansky JE, Thompson JM, Jain A, Pardoll DM, Schulick RD.

Cancer Res. 2007 Oct 15;67(20):10058-66.

3.

Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases.

Olino K, Wada S, Edil BH, Pan X, Meckel K, Weber W, Slansky J, Tamada K, Lauer P, Brockstedt D, Pardoll D, Schulick R, Yoshimura K.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S597-607. doi: 10.1245/s10434-011-2037-0. Epub 2011 Oct 7.

4.

Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy.

Singh M, Quispe-Tintaya W, Chandra D, Jahangir A, Venkataswamy MM, Ng TW, Sharma-Kharkwal S, Carreño LJ, Porcelli SA, Gravekamp C.

Br J Cancer. 2014 Nov 11;111(10):1945-54. doi: 10.1038/bjc.2014.486. Epub 2014 Oct 14.

5.

Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes.

Yoshimura K, Jain A, Allen HE, Laird LS, Chia CY, Ravi S, Brockstedt DG, Giedlin MA, Bahjat KS, Leong ML, Slansky JE, Cook DN, Dubensky TW, Pardoll DM, Schulick RD.

Cancer Res. 2006 Jan 15;66(2):1096-104.

6.

Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1.

Singh M, Ramos I, Asafu-Adjei D, Quispe-Tintaya W, Chandra D, Jahangir A, Zang X, Aggarwal BB, Gravekamp C.

Cancer Med. 2013 Aug;2(4):571-82. doi: 10.1002/cam4.94. Epub 2013 Jul 2.

7.

Listeria-based cancer vaccines that segregate immunogenicity from toxicity.

Brockstedt DG, Giedlin MA, Leong ML, Bahjat KS, Gao Y, Luckett W, Liu W, Cook DN, Portnoy DA, Dubensky TW Jr.

Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13832-7. Epub 2004 Sep 13.

9.

Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.

Chen Y, Yang D, Li S, Gao Y, Jiang R, Deng L, Frankel FR, Sun B.

Oncogene. 2012 Apr 26;31(17):2140-52. doi: 10.1038/onc.2011.395. Epub 2011 Sep 19. Erratum in: Oncogene. 2012 Nov 8;31(45):4810.

PMID:
21927025
10.

AsGM1+ NK cells prevent metastasis of invading LD-MCA-38 tumor cells in the nude mouse.

Volpe CM, Mehta N, Kim U, Hordines J, Doerr RJ, Cohen SA.

J Surg Res. 1999 Jun 15;84(2):157-61.

PMID:
10357913
11.

Rapid development of a gamma interferon-secreting glycolipid/CD1d-specific Valpha14+ NK1.1- T-cell subset after bacterial infection.

Emoto M, Yoshizawa I, Emoto Y, Miamoto M, Hurwitz R, Kaufmann SH.

Infect Immun. 2006 Oct;74(10):5903-13.

12.
13.

Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice.

Chandra D, Jahangir A, Quispe-Tintaya W, Einstein MH, Gravekamp C.

Br J Cancer. 2013 Jun 11;108(11):2281-90. doi: 10.1038/bjc.2013.206. Epub 2013 May 2.

14.

Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent?

Saltzman DA, Katsanis E, Heise CP, Hasz DE, Vigdorovich V, Kelly SM, Curtiss R 3rd, Leonard AS, Anderson PM.

J Pediatr Surg. 1997 Feb;32(2):301-6.

PMID:
9044141
15.

Cyclooxygenase-2 inhibition augments the hepatic antitumor effect of oral Salmonella typhimurium in a model of mouse metastatic colon cancer.

Feltis BA, Sahar DA, Kim AS, Saltzman DA, Leonard AS, Sielaff TD.

Dis Colon Rectum. 2002 Aug;45(8):1023-8.

PMID:
12195185
17.

Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.

Liu LL, Smith MJ, Sun BS, Wang GJ, Redmond HP, Wang JH.

Ann Surg Oncol. 2009 May;16(5):1403-11. doi: 10.1245/s10434-009-0343-6. Epub 2009 Mar 5.

PMID:
19263173
18.

Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer.

Hannan R, Zhang H, Wallecha A, Singh R, Liu L, Cohen P, Alfieri A, Rothman J, Guha C.

Cancer Immunol Immunother. 2012 Dec;61(12):2227-38. doi: 10.1007/s00262-012-1257-x. Epub 2012 May 27.

PMID:
22644735
19.

Beta-glucosylceramide administration (i.p.) activates natural killer T cells in vivo and prevents tumor metastasis in mice.

Inafuku M, Li C, Kanda Y, Kawamura T, Takeda K, Oku H, Watanabe H.

Lipids. 2012 Jun;47(6):581-91. doi: 10.1007/s11745-012-3666-1. Epub 2012 Mar 20.

PMID:
22426862
20.

Supplemental Content

Support Center